Annual Drug Patent Expirations for IBRANCE Ibrance is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. There are six patents protecting…
The post New patent for Pfizer drug IBRANCE appeared first on DrugPatentWatch - Make Better Decisions.